Sanofi Plans Ingredients Unit IPO Within Months: Report
Paris: Sanofi, the French pharmaceutical giant, plans to sell shares in its drug-ingredients division in the next few months, a senior executive said.
"We'll try to launch it on the market," Sanofi France Chairman Olivier Bogillot said on France Inter radio on Saturday. "We'll do an IPO in the coming months."
Sanofi has said the move will help ensure supplies of essential components used to make medicines and reduce the industry's heavy reliance on Asia, which was exposed at the beginning of the coronavirus outbreak.
The unit is combining Sanofi's commercial and development activities with six of its European production sites, including facilities in Frankfurt and Brindisi, Italy.
Read also: Sanofi, GSK begin human trial of coronavirus vaccine candidate
